| Literature DB >> 32050285 |
Victoria Susanne Antonia Habbel1, Elisa Annabelle Mahler2, Bernd Feyerabend3, Karl-Jürgen Oldhafer1, Michael Josef Lipp1.
Abstract
Diffuse malignant peritoneal mesothelioma (DMPM) is a rare diagnosis, found more frequently in men than in women. Symptoms are unspecific abdominal disorders making that diagnosis difficult to set. Causes of DMPM are yet to be discovered in entirety. Asbestos exposure is the reason for approximately 7 % of all peritoneal mesotheliomas. Until the evaluation of systematic cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC) DMPM was a fatal diagnosis with a median overall survival (OS) of 4-13 months. The prognosis of DMPM dramatically improved with implementation of CRS and HIPEC to an OS of 30-92 month nowadys. CRS and HIPEC were performed in this case. © Georg Thieme Verlag KG Stuttgart · New York.Entities:
Year: 2020 PMID: 32050285 DOI: 10.1055/a-1083-6962
Source DB: PubMed Journal: Z Gastroenterol ISSN: 0044-2771 Impact factor: 2.000